Published January 1, 2013
| Version v1
Journal article
Open
Dexmedetomidine ameliorates TNBS-induced colitis by inducing immunomodulator effect
Creators
- 1. Inonu Univ, Turgut Ozal Med Ctr, Fac Med, Dept Anesthesiol & Reanimat, TR-44100 Malatya, Turkey
- 2. Inonu Univ, Turgut Ozal Med Ctr, Fac Med, Dept Histol & Embryol, TR-44100 Malatya, Turkey
- 3. Inonu Univ, Turgut Ozal Med Ctr, Fac Med, Dept Med Biol & Genet, TR-44100 Malatya, Turkey
Description
Background: Since sedatives are often administered to immune-compromised and critically ill patients, our understanding of immunomodulation by sedation will be critical. Dexmedetomidine, a selective alpha(2)-adrenergic receptor agonist, is often used for sedation and analgesia especially in intensive care units. There are conflicting and little data concerning both the effect and the mechanism of dexmedetomidine on immune response. In our study, we aimed to investigate the effect of dexmedetomidine on immune system at two different doses (5 mu g.kg(-1) and 30 mu g.kg(-1)) during inflammatory bowel disease by using an experimental model, which resembles both systemic and local inflammation.
Files
bib-11c481ab-7f3f-4029-81b5-a2599de2dd49.txt
Files
(231 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:7fd65062f50ad973f34da7de9ab030d8
|
231 Bytes | Preview Download |